{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:51:44Z","timestamp":1786985504315,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.breast.2024.103854","type":"journal-article","created":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:57:22Z","timestamp":1732589842000},"page":"103854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1024-3519","authenticated-orcid":false,"given":"Roxanne A.W.","family":"Ploumen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiemo J.A.","family":"van Nijnatten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loes F.S.","family":"Kooreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien B.M.I.","family":"Keymeulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Siesling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2024.103854_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1066007","article-title":"Review of the status of neoadjuvant therapy in HER2-positive breast cancer","volume":"13","author":"Dowling","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib2","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1200\/JCO.1998.16.8.2672","article-title":"Effect of preoperative chemotherapy on the outcome of women with operable breast cancer","volume":"16","author":"Fisher","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/jnci\/dji021","article-title":"Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis","volume":"97","author":"Mauri","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.breast.2024.103854_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","article-title":"Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis","volume":"384","author":"Cortazar","year":"2014","journal-title":"Lancet"},{"issue":"Suppl 1","key":"10.1016\/j.breast.2024.103854_bib5","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.breast.2022.01.008","article-title":"Breast and axillary surgery after neoadjuvant systemic treatment - a review of clinical routine recommendations and the latest clinical research","volume":"62","author":"Pfob","year":"2022","journal-title":"Breast"},{"key":"10.1016\/j.breast.2024.103854_bib6","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/S1470-2045(18)30570-9","article-title":"Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial","volume":"19","author":"van Ramshorst","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib7","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1093\/annonc\/mdt182","article-title":"Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA)","volume":"24","author":"Schneeweiss","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib8","year":"2017","journal-title":"Dutch Guideline \u2018Treatment of breast cancer\u2019 (Richtlijn \u2018Behandeling van het Mammacarcinoom\u2019)"},{"key":"10.1016\/j.breast.2024.103854_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up\u2606","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/canjclin.52.5.277","article-title":"Standard for breast conservation therapy in the management of invasive breast carcinoma","volume":"52","author":"Morrow","year":"2002","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.breast.2024.103854_bib11","doi-asserted-by":"crossref","first-page":"9934","DOI":"10.1038\/s41598-019-46309-2","article-title":"Overall survival is improved when DCIS accompanies invasive breast cancer","volume":"9","author":"Kole","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.breast.2024.103854_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10549-023-07012-z","article-title":"Pathologic complete response of ductal carcinoma in situ to neoadjuvant systemic therapy in HER2-positive invasive breast cancer patients: a nationwide analysis","volume":"201","author":"Ploumen","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.bjc.6605655","article-title":"Presence of an in situ component is associated with reduced biological aggressiveness of size-matched invasive breast cancer","volume":"102","author":"Wong","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2024.103854_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10549-016-3862-4","article-title":"Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study","volume":"158","author":"Doebar","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib15","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-021-06235-2","article-title":"Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer","volume":"189","author":"Groen","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib16","year":"2008","journal-title":"Dutch Guideline \u2018Treatment of breast cancer\u2019 (Richtlijn \u2018Behandeling van het Mammacarcinoom\u2019)"},{"key":"10.1016\/j.breast.2024.103854_bib17","year":"2012","journal-title":"Dutch Guideline \u2018Treatment of breast cancer\u2019 (Richtlijn \u2018Behandeling van het Mammacarcinoom\u2019)"},{"key":"10.1016\/j.breast.2024.103854_bib18","series-title":"Flexible imputation of missing data","first-page":"29","article-title":"Multiple imputation","author":"Rubin","year":"2018"},{"key":"10.1016\/j.breast.2024.103854_bib19","article-title":"The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: a multicenter real-world study (CSBrS-012)","volume":"11","author":"Li","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.breast.2024.103854_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/bjs.10807","article-title":"Meta-analysis of neoadjuvant therapy and its impact in facilitating breast conservation in operable breast cancer","volume":"105","author":"Karakatsanis","year":"2018","journal-title":"Br J Surg"},{"key":"10.1016\/j.breast.2024.103854_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s10549-008-9959-7","article-title":"Conservative surgery in patients with multifocal\/multicentric breast cancer","volume":"113","author":"Gentilini","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib22","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10549-013-2772-y","article-title":"Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients","volume":"142","author":"Wolters","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib23","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1200\/JCO.2006.07.6067","article-title":"Locoregional control of clinically diagnosed multifocal or multicentric breast cancer after neoadjuvant chemotherapy and locoregional therapy","volume":"24","author":"Oh","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/bjs5.53","article-title":"Systematic review of the impact of breast-conserving surgery on cancer outcomes of multiple ipsilateral breast cancers","volume":"2","author":"Winters","year":"2018","journal-title":"BJS Open"},{"key":"10.1016\/j.breast.2024.103854_bib25","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1245\/s10434-014-4122-7","article-title":"Impact of multifocal or multicentric disease on surgery and locoregional, distant and overall survival of 6,134 breast cancer patients treated with neoadjuvant chemotherapy","volume":"22","author":"Ataseven","year":"2015","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib26","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.1245\/s10434-019-07533-2","article-title":"Patient selection for clinical trials eliminating surgery for HER2-positive breast cancer treated with neoadjuvant systemic therapy","volume":"26","author":"Sun","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib27","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s10549-011-1621-0","article-title":"Responsiveness of adjacent ductal carcinoma in situ and changes in HER2 status after neoadjuvant chemotherapy\/trastuzumab treatment in early breast cancer--results from the GeparQuattro study (GBG 40)","volume":"132","author":"von Minckwitz","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib28","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1007\/s00330-023-09547-7","article-title":"Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis","volume":"33","author":"Ploumen","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.breast.2024.103854_bib29","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200301","article-title":"The diagnostic performance of CESM and CE-MRI in evaluating the pathological response to neoadjuvant therapy in breast cancer: a systematic review and meta-analysis","volume":"93","author":"Tang","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.breast.2024.103854_bib30","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.clbc.2016.12.010","article-title":"Role of magnetic resonance imaging in detection of pathologic complete remission in breast cancer patients treated with neoadjuvant chemotherapy: a meta-analysis","volume":"17","author":"Gu","year":"2017","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2024.103854_bib31","article-title":"Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted magnetic resonance imaging for predicting the response of locally advanced breast cancer to neoadjuvant therapy: a meta-analysis","volume":"5","author":"Virostko","year":"2018","journal-title":"J Med Imaging"},{"key":"10.1016\/j.breast.2024.103854_bib32","doi-asserted-by":"crossref","first-page":"5526","DOI":"10.1200\/JCO.2005.06.217","article-title":"Patient involvement in surgery treatment decisions for breast cancer","volume":"23","author":"Katz","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib33","doi-asserted-by":"crossref","first-page":"e539","DOI":"10.1016\/j.clbc.2017.12.013","article-title":"Review of factors influencing women's choice of mastectomy versus breast conserving therapy in early stage breast cancer: a systematic review","volume":"18","author":"Gu","year":"2018","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.breast.2024.103854_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2023.103600","article-title":"Key factors in the decision-making process for mastectomy alone or breast reconstruction: a qualitative analysis","volume":"73","author":"Blackmore","year":"2024","journal-title":"Breast"},{"key":"10.1016\/j.breast.2024.103854_bib35","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3747\/co.26.4305","article-title":"Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives","volume":"26","author":"Dicks","year":"2019","journal-title":"Curr Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib36","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fonc.2016.00074","article-title":"Decision-making in the surgical treatment of breast cancer: factors influencing women's choices for mastectomy and breast conserving surgery","volume":"6","author":"Bellavance","year":"2016","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2024.103854_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11912-019-0860-9","article-title":"Increasing role of oncoplastic surgery for breast cancer","volume":"21","author":"Kaufman","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.breast.2024.103854_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-007698","article-title":"Protocol for a pre-implementation and post-implementation study on shared decision-making in the surgical treatment of women with early-stage breast cancer","volume":"5","author":"Savelberg","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.breast.2024.103854_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/hex.13368","article-title":"Development of a patient decision aid for patients with breast cancer who consider immediate breast reconstruction after mastectomy","volume":"25","author":"Ter Stege","year":"2022","journal-title":"Health Expect"},{"key":"10.1016\/j.breast.2024.103854_bib40","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamasurg.2013.5689","article-title":"Social and clinical determinants of contralateral prophylactic mastectomy","volume":"149","author":"Hawley","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/j.breast.2024.103854_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s10549-016-3697-z","article-title":"Low prevalence of HER2 positivity amongst BRCA1 and BRCA2 mutation carriers and in primary BRCA screens","volume":"155","author":"Evans","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103854_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100531","article-title":"Characterization of the HER2 status in BRCA-mutated breast cancer: a single institutional series and systematic review with pooled analysis","volume":"7","author":"Tomasello","year":"2022","journal-title":"ESMO Open"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T06:03:43Z","timestamp":1739253823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":42,"alternative-id":["S0960977624001851"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103854","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surgical treatment after neoadjuvant systemic therapy for HER2-positive invasive breast cancer in the Netherlands: 10-Year trends and the influence an accompanying DCIS component","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103854","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103854"}}